Sale

MRSA Testing Market

Global MRSA Testing Market Size, Trends, Research, Analysis: By Test Type: Molecular Diagnostic Tests, Immunodiagnostic Tests; By End Use: Hospitals, Diagnostic and Pathology Centres, Academic and Research Institutes, Others; Regional Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032

Global MRSA Testing Market Outlook

The global MRSA testing market size is expected to grow at a CAGR of 12.20% during the forecast period of 2024-2032. The development of the market is driven by the continuous developments in diagnostic devices and the increasing prevalence of MRSA infections globally.

 

Global MRSA Testing Market Trends

MRSA stands for methicillin-resistant Staphylococcus aureus, and is a type of bacteria that is resistant to some of the most widely used antibiotics. MRSA testing is a diagnostic procedure that is utilized to search for MRSA bacteria. The testing is done through a sample extracted from a wound, nostril, or other body fluids.

 

  • The MRSA testing market demand is driven by the increasing prevalence of MRSA infections globally, which has simultaneously propelled the demand for effective diagnostic techniques that can detect MSRA infection properly.
     
  • Rising demand for POC (point of care) diagnostics in MRSA is expected to drive the market growth. The technological developments in POC devices and test procedures that enable improved diagnosis is expected to drive the market growth.
     
  • Growing investments by market players in research and development to introduce new and innovative devices and procedures are likely to enhance the market value. The market players are also focused on expanding their market reach and solidifying their presence in other regions, and this can further augment the market expansion.

 

Global MRSA Testing Market Analysis

Based on test type, the market can be segmented into molecular diagnostic tests and immunodiagnostic tests. Based on the end-use, it can be bifurcated into hospitals, diagnostic and pathology centres, academic and research institutes, among others. The regional markets for the MSRA testing market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. 

 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the MRSA testing companies, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans. 

 

  • F.Hoffmann-La Roche
     
  • Hain Lifescience GmbH
     
  • Becton, Dickinson and Company
     
  • Alifax S.r.l.
     
  • bioMérieux SA
     
  • ZeptoMetrix Corporation
     
  • Abacus Diagnostica Oy
     
  • Others

 

End-Uses of MRSA Testing Methods

Based on end-use, the MRSA testing market is segmented into hospitals, diagnostic and pathology centres, academic and research institutes, among others. Among these segments, hospitals are expected to cover a major portion of the market.

 

This segment is likely to dominate the market during the forecast period owing to the first preference of people as a one-stop solution and the wide array of healthcare services provided. Also, the adoption of advanced technologies and diagnostic procedures is expected to further propel the market growth.

 

Regional Outlook 

The major regions in the MRSA testing market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

 

North America is likely to be the dominating region in the global market owing to the growing awareness among people about MRSA infection and the testing methods provided by healthcare facility providers. The presence of established market players and increasing investments by the market players in research and development for the development of effective diagnostic methods can propel the market growth.

 

mrsa testing market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

F.Hoffmann-La Roche, more commonly known as Roche, is a Swiss healthcare company that operates globally in two market divisions including pharmaceuticals and diagnostics. It is one of the key players in the MRSA testing market. The company is a part of Roche Holding, its parent organization. The company's headquarter is located in Basel, Switzerland, and was founded in 1896. The company is focused on research and development, manufacture, and distribution of drugs related to diseases such as cancer, viral infections, metabolic, central nervous system disorders, and inflammatory diseases, among other healthcare products.

 

Hain Lifescience GmbH is a German-based modern and innovative diagnostic company that is engaged in the manufacturing and distribution of molecular diagnosis systems. The company operates with the aim to provide improved solutions for laboratories to enable reliable and sound diagnostics and provide the most relevant and optimal treatment to patients.

 

Becton, Dickinson and Company is one world’s largest medical technology manufacturing companies. The company has been operating since 1897 in the field of medical technology with an aim to improve world healthcare by innovating medical discovery, diagnostics, and delivery of medical care. The company's headquarter is located in New Jersey, United States. It specialises in various fields of healthcare including medical devices, biosciences, medical supplies, reagents, and diagnostics products, among many other related products.

 

Other market players include Alifax S.r.l., bioMérieux SA, ZeptoMetrix Corporation, and Abacus Diagnostica Oy, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Test Type
  • End Use
  • Region
Breakup by Test Type
  • Molecular Diagnostic Tests
  • Immunodiagnostic Tests
Breakup by End Use
  • Hospitals
  • Diagnostic and Pathology Centres
  • Academic and Research Institutes
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • F.Hoffmann-La Roche
  • Hain Lifescience GmbH
  • Becton, Dickinson and Company
  • Alifax S.r.l.
  • bioMérieux SA
  • ZeptoMetrix Corporation
  • Abacus Diagnostica Oy
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Opportunities and Challenges in the Market
8    Global MRSA Testing Market Analysis

    8.1    Key Industry Highlights
    8.2    Global MRSA Testing Historical Market (2018-2023) 
    8.3    Global MRSA Testing Market Forecast (2024-2032)
    8.4    Global MRSA Testing Market by Test Type
        8.4.1    Molecular Diagnostic Tests
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2023)
            8.4.1.3    Forecast Trend (2024-2032)
        8.4.2    Immunodiagnostic Tests
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2023)
            8.4.2.3    Forecast Trend (2024-2032)
    8.5    Global MRSA Testing Market by End Use
        8.5.1    Hospitals
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2023)
            8.5.1.3    Forecast Trend (2024-2032)
        8.5.2    Diagnostic and Pathology Centres
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2023)
            8.5.2.3    Forecast Trend (2024-2032)
        8.5.3    Academic and Research Institutes
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2023)
            8.5.3.3    Forecast Trend (2024-2032)
        8.5.4    Others
    8.6    Global MRSA Testing Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2023) 
            8.6.1.3    Forecast Trend (2024-2032)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2023) 
            8.6.2.3    Forecast Trend (2024-2032)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2023) 
            8.6.3.3    Forecast Trend (2024-2032)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2023) 
            8.6.4.3    Forecast Trend (2024-2032)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2023) 
            8.6.5.3    Forecast Trend (2024-2032)
9    North America Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2023) 
        9.1.3    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2023) 
        9.2.3    Forecast Trend (2024-2032)
10    Europe Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2023) 
        10.1.3    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2023) 
        10.2.3    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2023) 
        10.3.3    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2023) 
        10.4.3    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2023) 
        11.1.3    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2023) 
        11.2.3    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2023) 
        11.3.3    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2023) 
        11.4.3    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2023) 
        11.5.3    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2023) 
        12.1.3    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2023) 
        12.2.3    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2023) 
        12.3.3    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2023) 
        13.1.3    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2023) 
        13.2.3    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2023) 
        13.3.3    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2023) 
        13.4.3    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    F.Hoffmann-La Roche
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Hain Lifescience GmbH
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Becton, Dickinson and Company
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Alifax S.r.l.
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    bioMérieux SA
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    ZeptoMetrix Corporation
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Abacus Diagnostica Oy
            15.2.7.1    Company Overview
            15.2.7.2    Product Portfolio
            15.2.7.3    Demographic Reach and Achievements
            15.2.7.4    Certifications
        15.2.8    Others
16    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global MRSA Testing Market: Key Industry Highlights, 2018 and 2032
2.    Global MRSA Testing Historical Market: Breakup by Test Type (USD Million), 2018-2023
3.    Global MRSA Testing Market Forecast: Breakup by Test Type (USD Million), 2024-2032
4.    Global MRSA Testing Historical Market: Breakup by End Use (USD Million), 2018-2023
5.    Global MRSA Testing Market Forecast: Breakup by End Use (USD Million), 2024-2032
6.    Global MRSA Testing Historical Market: Breakup by Region (USD Million), 2018-2023
7.    Global MRSA Testing Market Forecast: Breakup by Region (USD Million), 2024-2032
8.    North America MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2023
9.    North America MRSA Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
10.    Europe MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2023
11.    Europe MRSA Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Asia Pacific MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Asia Pacific MRSA Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Latin America MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Latin America MRSA Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Middle East and Africa MRSA Testing Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Middle East and Africa MRSA Testing Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Global MRSA Testing Market Structure.

Key Questions Answered in the Report

The market is expected to grow at a CAGR of 12.20% during the forecast period of 2024-2032.

The market is driven by the growing demand for advanced diagnostic and testing methods and increasing efforts for research and development by key players in the market.

The rising opportunities for growth in developing regions and growing awareness of MRSA infections and diagnostic methods are expected to deliver new growth opportunities to the market.

The regional markets for the global MRSA testing market include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

The test types available in the market are molecular diagnostic tests and immunodiagnostic tests.

MRSA testing is utilized by hospitals, diagnostic and pathology centres, academic and research institutes, among others.

The key players in the market include F.Hoffmann-La Roche, Hain Lifescience GmbH, Becton, Dickinson and Company, Alifax S.r.l., bioMérieux SA, ZeptoMetrix Corporation, and Abacus Diagnostica Oy, among others.

Purchase Full Report

Mini Report

$ 2199     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3299     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 4399     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5499     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER